Courtney Phillips sold $105K of MAZE
Courtney Phillips (GC and Corp. Secretary) sold 3,993 shares of Maze Therapeutics, Inc. (MAZE) at an average of $26.24 ($25.78–$27.12, $0.10M total) across 4 trades over 2026-09-02 to 2026-09-03.
How this was made
The 30-second read
Why it matters
The sale represents a modest reduction in insider ownership, unlikely to affect investor sentiment significantly.
Market read
Small insider sell; limited trading relevance.
What to watch
No 10b5‑1 plan and the insider remains a significant holder (7,007 shares).
Background
Form 4 filings provide the first public disclosure of insider transactions.
Ticker impact
SEC Form 4 disclosed insider Courtney Phillips sold ~ $105K of Maze Therapeutics shares.
Limited downside pressure, likely negligible price change.
Sale size is small relative to market cap and no 10b5-1 plan; typical insider sells have limited impact.
Market effects
None; transaction is company‑specific.
None; limited to U.S. biotech sector.
Minimal.
Counterpoint
Insider may be reallocating capital; could be a neutral or even positive signal if cash is used for growth.
Key entities
- OfficerCourtney Phillips
General Counsel and Corporate Secretary of Maze Therapeutics.
- CompanyMaze Therapeutics, Inc.
Biotech firm developing precision medicines for rare diseases.
